These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31295958)

  • 1. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.
    Haupt VJ; Daminelli S; Schroeder M
    PLoS One; 2013; 8(6):e65894. PubMed ID: 23805191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing Promiscuity at the Level of Active Compounds and Targets.
    Bajorath J
    Mol Inform; 2016 Dec; 35(11-12):583-587. PubMed ID: 27870240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacology: in silico methods of ligand design and development.
    McKie SA
    Future Med Chem; 2016 Apr; 8(5):579-602. PubMed ID: 27105127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein promiscuity: drug resistance and native functions--HIV-1 case.
    Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
    J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the tendency of therapeutic target proteins to bind promiscuous or selective compounds.
    Hu Y; Bajorath J
    PLoS One; 2015; 10(5):e0126838. PubMed ID: 26000736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity.
    Park K; Lee S; Ahn HS; Kim D
    Mol Biosyst; 2009 Aug; 5(8):844-53. PubMed ID: 19603120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates to Binding MOAD (Mother of All Databases): Polypharmacology Tools and Their Utility in Drug Repurposing.
    Smith RD; Clark JJ; Ahmed A; Orban ZJ; Dunbar JB; Carlson HA
    J Mol Biol; 2019 Jun; 431(13):2423-2433. PubMed ID: 31125569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying and characterizing promiscuous targets: implications for virtual screening.
    Pérez-Nueno VI; Ritchie DW
    Expert Opin Drug Discov; 2012 Jan; 7(1):1-17. PubMed ID: 22468890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Promiscuous Compounds with Activity against Different Target Classes.
    Feldmann C; Miljković F; Yonchev D; Bajorath J
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug promiscuity].
    Guo ZR
    Yao Xue Xue Bao; 2011 Apr; 46(4):361-9. PubMed ID: 21751487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of contact residue disorder and domain composition in characterizing protein-ligand binding specificity and promiscuity.
    Tang Y; Sheng X; Stumpf MP
    Mol Biosyst; 2011 Dec; 7(12):3280-6. PubMed ID: 22002096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical Profiling of One Promiscuous Protein Binding Site: Illustrated by Urokinase Catalytic Domain.
    Cerisier N; Regad L; Triki D; Petitjean M; Flatters D; Camproux AC
    Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28696518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive survey of small-molecule binding pockets in proteins.
    Gao M; Skolnick J
    PLoS Comput Biol; 2013 Oct; 9(10):e1003302. PubMed ID: 24204237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
    Miljković F; Bajorath J
    J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting similar binding pockets to enable systems polypharmacology.
    Duran-Frigola M; Siragusa L; Ruppin E; Barril X; Cruciani G; Aloy P
    PLoS Comput Biol; 2017 Jun; 13(6):e1005522. PubMed ID: 28662117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances.
    Bolz SN; Schroeder M
    Expert Opin Drug Discov; 2023; 18(9):973-985. PubMed ID: 37489516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTLD, a Database of Multiple Target Ligands, the Updated Version.
    Chen C; Wu M; Cen S; Wu J; Zhou J
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28878188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.